These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21365257)

  • 1. A comparison of stem cells for therapeutic use.
    Rodgerson DO; Harris AG
    Stem Cell Rev Rep; 2011 Nov; 7(4):782-96. PubMed ID: 21365257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead.
    Bhartiya D; Shaikh A; Anand S; Patel H; Kapoor S; Sriraman K; Parte S; Unni S
    Hum Reprod Update; 2016 Dec; 23(1):41-76. PubMed ID: 27614362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonic stem cells and iPS cells: sources and characteristics.
    Hackett CH; Fortier LA
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):233-42. PubMed ID: 21872756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The stem cells and a problem of regeneration of peripheral nerves].
    Diel'tsova OI; Herashchenko SB; Chaĭkovskyĭ IuB
    Klin Khir; 2013 Jul; (7):65-8. PubMed ID: 24283050
    [No Abstract]   [Full Text] [Related]  

  • 5. Do we have a workable clinical protocol for differentiating lympho-hematopoietic stem cells from the source of embryonic stem cells and induced pluripotent stem cells in culture?
    Chen U
    Scand J Immunol; 2014 Oct; 80(4):247-9. PubMed ID: 25041639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesodermal and hematopoietic differentiation from ES and iPS cells.
    Inoue-Yokoo T; Tani K; Sugiyama D
    Stem Cell Rev Rep; 2013 Aug; 9(4):422-34. PubMed ID: 22684542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells.
    Lim WF; Inoue-Yokoo T; Tan KS; Lai MI; Sugiyama D
    Stem Cell Res Ther; 2013 Jun; 4(3):71. PubMed ID: 23796405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From stem cells to red blood cells: how far away from the clinical application?
    Xie X; Li Y; Pei X
    Sci China Life Sci; 2014 Jun; 57(6):581-5. PubMed ID: 24829108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
    Yoshida Y; Yamanaka S
    Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
    Park TS; Zimmerlin L; Zambidis ET
    Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells from blastomeres maintaining embryo viability.
    Klimanskaya I
    Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
    Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
    Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
    Chicha L; Feki A; Boni A; Irion O; Hovatta O; Jaconi M
    PLoS One; 2011 Feb; 6(2):e14733. PubMed ID: 21364915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
    Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
    Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mysteries of induced pluripotency: where will they lead?
    Nagy A; Nagy K
    Nat Methods; 2010 Jan; 7(1):22-4. PubMed ID: 20038951
    [No Abstract]   [Full Text] [Related]  

  • 16. Induced pluripotent stem cells: origins, applications, and future perspectives.
    Zhao J; Jiang WJ; Sun C; Hou CZ; Yang XM; Gao JG
    J Zhejiang Univ Sci B; 2013 Dec; 14(12):1059-69. PubMed ID: 24302707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Reviews and Reports: Induced Pluripotent Stem Cells, Embryonic Stem Cells and Development Section.
    Ulrich H
    Stem Cell Rev Rep; 2017 Feb; 13(1):3. PubMed ID: 28168349
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion.
    Ebihara Y; Ma F; Tsuji K
    Int J Hematol; 2012 Jun; 95(6):610-6. PubMed ID: 22648827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.
    Galende E; Karakikes I; Edelmann L; Desnick RJ; Kerenyi T; Khoueiry G; Lafferty J; McGinn JT; Brodman M; Fuster V; Hajjar RJ; Polgar K
    Cell Reprogram; 2010 Apr; 12(2):117-25. PubMed ID: 20677926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial niche substrates for embryonic and induced pluripotent stem cell cultures.
    Joddar B; Ito Y
    J Biotechnol; 2013 Oct; 168(2):218-28. PubMed ID: 23707375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.